1-5 of 5
Jitesh Kawedia, BPharm
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Randomized Study of Pretransplant Conditioning Therapy for AML/MDS with Fludarabine ± Clofarabine and Once Daily IV Busulfan with Allogeneic Hematopoietic Transplantation for AML and MDS

Borje S. Andersson, MD, PhD, Peter Thall, Benigno C. Valdez, PhD, Junsheng Ma, MS, Julianne Chen, Sairah Ahmed, MD, Amin M. Alousi, MD, Qaiser Bashir, MD, Stefan O. Ciurea, MD, Alison Gulbis, Chitra Hosing, MD, Roy B. Jones, MD PhD, Jitesh Kawedia, BPharm, Partow Kebriaei, MD, Steven M. Kornblau, MD, Alan Myers, PharmD, PhD RPh, Betul Oran, MDMS, Katayoun Rezvani, MD PhD, Nina Shah, MD, Elizabeth J. Shpall, MD, Simrit Parmar, MD, MSCI, Uday R. Popat, MD, Yago Nieto, MD, Richard E. Champlin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-142680
Published: 2020
Journal Articles

Trial in Progress: A Prospective Phase I/II Trial to Jointly Optimize the Administration Schedule(s) and Dose(s) of Melphalan for Injection (Evomela) As a Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma

Qaiser Bashir, MD, Peter F Thall, PhD, Dawen Sui, Cristina Knape, Jitesh Kawedia, BPharm, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-139853
Published: 2020
Journal Articles

Myeloablative Fractionated Busulfan with Fludarabine in Older Patients: Long Term Outcomes of Prospective Phase II Clinical Trial

Rohtesh S. Mehta, MDMPH,MS, Roland Bassett, Julianne Chen, Benigno C. Valdez, PhD, Jitesh Kawedia, BPharm, Amin M. Alousi, MD, Gheath Alatrash, Qaiser Bashir, MD, Stefan Ciurea, MD, Chitra Hosing, MD, Jin S. Im, Partow Kebriaei, MD, Amanda L. Olson, Betul Oran, MDMS, Muzaffar H. Qazilbash, MD, Samer A. Srour, MD MS, Elizabeth J. Shpall, MD, Borje S. Andersson, MD, PhD, Richard E. Champlin, MD, Uday R. Popat, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-139325
Published: 2020
Journal Articles

A Randomized Study of Fludarabine-Clofarabine Vs Fludarabine Alone Combined with Busulfan and Allogeneic Hematopoietic Transplantation for AML and MDS

Richard E. Champlin, MD, Uday Popat, MD, Betul Oran, MDMS, Stefan O. Ciurea, MD, Partow Kebriaei, MD, Amin M. Alousi, MD, Gheath Alatrash, DO, PhD, Qaiser Bashir, MBBS, Issa F. Khouri, MD, Chitra Hosing, MD, Paolo Anderlini, Roy B Jones, MD PhD, David Marin, MD, Rohtesh Mehta, MD, Yago Nieto, MD PhD, Amanda L. Olson, MD, Muzaffar H. Qazilbash, MD, Katy Rezvani, MD PhD, Elizabeth J. Shpall, MD, Julianne Chen, Gabriela Rondon, MD, Becky McMullin, Vivian P Al Jahdhami, RN, Jitesh Kawedia, BPharm, Benigno C. Valdez, PhD, Junsheng Ma, MS, Peter F Thall, Borje S Andersson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 257.
https://doi.org/10.1182/blood-2019-124921
Published: 2019
Journal Articles

A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma

Muzaffar H. Qazilbash, MD, Qaiser Bashir, MD MBBS, Peter F Thall, Denái R. Milton, Nina Shah, MD, Krina K. Patel, MDMSc, Borje S Andersson, MDPhD, Yago Nieto, MD PhD, Partow Kebriaei, MD, Benigno C. Valdez, PhD, Jitesh Kawedia, BPharm, Simrit Parmar, MBBS, Ruby Delgado, Sairah Ahmed, MD, Chitra Hosing, MD, Uday Popat, MD, Elizabeth J Shpall, MD, Donna M. Weber, MD, Sheeba K. Thomas, MD, Elisabet E. Manasanch, MD, Hans C. Lee, MD, Robert Z. Orlowski, MD PhD, Richard E Champlin, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 399.
https://doi.org/10.1182/blood.V130.Suppl_1.399.399
Published: 2017